Viking Global Investors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,412,701
| Closed | -$628M | – | 88 |
|
|
2023
Q2 | $628M | Sell |
1,412,701
-741,855
| -34% | -$342M | 2.57% | 12 |
|
|
2023
Q1 | $991M | Buy |
2,154,556
+282,380
| +15% | +$134M | 4.65% | 4 |
|
|
2022
Q4 | $960M | Sell |
1,872,176
-464,665
| -20% | -$236M | 4.81% | 3 |
|
|
2022
Q3 | $1.06B | Buy |
2,336,841
+872,356
| +60% | +$417M | 4.9% | 1 |
|
|
2022
Q2 | $707M | Buy |
1,464,485
+1,323,590
| +939% | +$655M | 3.23% | 7 |
|
|
2022
Q1 | $69.2M | Buy |
+140,895
| New | +$64.4M | 0.28% | 69 |
|
|
2020
Q4 | – | Sell |
-522,405
| Closed | -$140M | – | 102 |
|
|
2020
Q3 | $140M | Buy |
+522,405
| New | +$141M | 0.51% | 52 |
|
|
2020
Q2 | – | Sell |
-1,810,632
| Closed | -$411M | – | 77 |
|
|
2020
Q1 | $411M | Sell |
1,810,632
-1,275,567
| -41% | -$348M | 2.14% | 16 |
|
|
2019
Q4 | $932M | Sell |
3,086,199
-787,206
| -20% | -$217M | 4.37% | 7 |
|
|
2019
Q3 | $930M | Sell |
3,873,405
-1,324,601
| -25% | -$363M | 4.84% | 5 |
|
|
2019
Q2 | $1.47B | Sell |
5,198,006
-996,880
| -16% | -$272M | 6.58% | 3 |
|
|
2019
Q1 | $1.78B | Buy |
6,194,886
+1,096,639
| +22% | +$317M | 10.19% | 1 |
|
|
2018
Q4 | $1.34B | Buy |
5,098,247
+315,448
| +7% | +$86.7M | 7.62% | 2 |
|
|
2018
Q3 | $1.31B | Buy |
4,782,799
+328,029
| +7% | +$85.2M | 7.26% | 3 |
|
|
2018
Q2 | $1.06B | Buy |
4,454,770
+25,222
| +0.6% | +$5.84M | 6.07% | 4 |
|
|
2018
Q1 | $973M | Buy |
4,429,548
+1,891,972
| +75% | +$444M | 5.86% | 3 |
|
|
2017
Q4 | $571M | Buy |
2,537,576
+1,664,112
| +191% | +$354M | 3.51% | 10 |
|
|
2017
Q3 | $166M | Buy |
873,464
+586,784
| +205% | +$112M | 1.07% | 28 |
|
|
2017
Q2 | $53.9M | Buy |
+286,680
| New | +$51.5M | 0.36% | 43 |
|
|
2016
Q2 | – | Sell |
-4,849,229
| Closed | -$674M | – | 60 |
|
|
2016
Q1 | $674M | Sell |
4,849,229
-1,837,736
| -27% | -$246M | 2.97% | 12 |
|
|
2015
Q4 | $932M | Buy |
6,686,965
+773,325
| +13% | +$107M | 3.52% | 9 |
|
|
2015
Q3 | $828M | Buy |
5,913,640
+4,006,939
| +210% | +$602M | 3.17% | 9 |
|
|
2015
Q2 | $313M | Buy |
+1,906,701
| New | +$305M | 1.18% | 28 |
|
|
2015
Q1 | – | Sell |
-1,003,959
| Closed | -$126M | – | 64 |
|
|
2014
Q4 | $126M | Sell |
1,003,959
-37,799
| -4% | -$4.67M | 0.58% | 40 |
|
|
2014
Q3 | $125M | Buy |
1,041,758
+87,473
| +9% | +$10M | 0.5% | 44 |
|
|
2014
Q2 | $103M | Buy |
+954,285
| New | +$98.3M | 0.45% | 42 |
|
Other funds holding ELV
Viking Global Investors's ELV Position: Q3 2023 in Review
Viking Global Investors sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 1,412,701 shares — an estimated $628M sold.
Viking Global Investors first reported a position in ELV in Q2 2014 and held it in 26 quarters. The position peaked at $1.78B in Q1 2019. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.
- Viking Global Investors reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
- Viking Global Investors sold 1,412,701 Elevance Health shares in Q3 2023, an estimated $628M.
- Viking Global Investors first reported a position in Elevance Health in Q2 2014 and held it in 26 quarters.
- Viking Global Investors's Elevance Health position peaked at $1.78B in Q1 2019.
- 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.
Based on Viking Global Investors's 13F filing for Q3 2023, filed 14 Nov 2023.